Abstract
The authors continue their discussion of pharmacological and nonpharmacological therapies with a focus on criteria for the best agent, the subtypes of breakthrough pain, and the economic and quality-of life considerations.
Original language | English (US) |
---|---|
Pages (from-to) | 354-361 |
Number of pages | 8 |
Journal | P and T |
Volume | 30 |
Issue number | 6 |
State | Published - Jun 2005 |
ASJC Scopus subject areas
- Pharmacology